The treatment of hyperphosphatemia was intensified by the additional mealtime administration of phosphate binders, such as aluminium hydroxide and calcium carbonate. Phosphate accumulation was ...

Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports ...